Dr. Adel Elomri is an Associate Professor in the Division of Engineering Management and Decision Sciences at the College of Science and Engineering, Hamad Bin Khalifa University. He holds a PhD and MSc with highest honors in supply chain and operations management from École Centrale Paris (CentraleSupélec), France, and a BS with highest honors in industrial engineering from the National Engineering School of Tunis (ENIT), Tunisia.

Dr. Adel Elomri is a scholar in operations management and supply chains, with expertise and research interests at the intersection of operations research, economics, and sustainability. His research explores how complex supply chains can be designed and managed, and his findings have been widely published, attracting significant funding. Dr. Elomri’s work spans three key areas: sustainable supply chain management, smart supply chains, and healthcare operations management.

Dr. Hira Amin is an Assistant Professor at the College of Public Policy at Hamad Bin Khalifa University. After completing her PhD in History at the University of Cambridge, she has been involved in various interdisciplinary projects. Her research interests broadly fall into two categories: the first is social, cultural, and religious transformations in the modern Muslim world; the second is social inclusion, accessibility, and disability.

She has undergone training in systems thinking, LEGO Serious Play, participatory co-design, and strategic foresight at the Institute for the Future. She is currently working on multiple research grants that utilize these various tools and methods, such as education for sustainability and global citizenship, strategic foresight in culture, identity, and education, and systems mapping the disability diagnostics landscape in Qatar.

Dr. Mutaz al-Khatib is currently Associate Professor of Methodology and Ethics at the Research Center for Islamic Legislation and Ethics (CILE), as well as the first-of-its-kind MA program in Applied Islamic Ethics at the College of Islamic Studies at Hamad Bin Khalifa University. He is a founding member of the Journal of Islamic Ethics and the Studies in Islamic Ethics book series, where he also serves as editor-in-chief of the latter. He holds a BA in Islamic Studies from Damascus (1997) and in Arabic Literature from Al-Azhar University. 

Al-Khatib was a founding member of al-Multaqā al-Fikrī li-l Ibdā’ (Intellectual Forum for Innovation, 1999), and the anchor of “Al Sharia wa-l Ḥayāt” program on Al Jazeera Channel (2004 -2013). He was also the Editor-in-Chief of the "Islam and Contemporary Affairs" section on IslamOnline.net (2003-2008). 

He was a visiting fellow at ZMO in Berlin (2006) and a visiting scholar at the Forum Transregionale Studien, Berlin (2012-2013), as well as a Visiting Lecturer at the American University of Beirut, the Islamic University of Beirut, and Qatar University. He has presented lectures at various reputable academic institutions, including University of Oxford, University of Cambridge, Princeton University, University of Florida, University of California, University of Tübingen, Ludwig-Maximilians-Universität München, and Lund University. 

He is a reviewer for a number of journals and has authored and edited several books and over 40 academic articles on Ḥadīth criticism, Islamic Ethics, Islamic intellectual history, Maqāṣid (the higher objectives of Sharia), and Islamic Law. He has also published extensively in Arabic-language newspapers and magazines.

Dr. Joseph Lumbard is Associate Professor of Quranic Studies at CIS. He has previously taught at the American University of Sharjah, Brandeis University, and the American University in Cairo. He also served as Advisor for Interfaith Affairs to the Jordanian Royal Court. He received his PhD in Islamic Studies from Yale University and has studied with scholars in Morocco, Egypt, Yemen, Jordan, and Iran. His scholarship contributes to the fields of Islamic philosophical theology, Sufism, and Quranic studies. He served as author, translator, and general editor for The Study Quran (HarperOne 2015), which has been heralded as one of the most important contributions to Islamic studies in the English language. His current research incorporates aspects of Quranic studies, philosophy, and theology to focus upon the development of epistemologies in Islam.

Dr. Dheen Mohamed is Program Director of the PhD program in Islamic Studies and Professor of Comparative Religion and Contemporary Quranic Studies at the College of Islamic Studies (CIS), Hamad Bin Khalifa University (HBKU). He earned his BA (Hons.), MA, and PhD in Theology and Philosophy from al‑Azhar University. Before joining HBKU in 2013, he served as Professor and Associate Dean for Academic Affairs at Qatar University (QU) and held senior academic roles as Dean, HoD, and Director of Academics at the International Islamic University, Islamabad (IIUI). His teaching and research span comparative religion, Sufism (taṣawwuf), contemporary Qur’anic studies, Islamic philosophy, and Islamic thought. Recent publications include the chapter “Introduction to Islam” in Contemporary Islamic Perspectives in Public Health (Cambridge University Press, 2025), and peer‑reviewed articles in Afkar (2024) and the Journal of Islamic Thought and Civilization (2024). He has supervised more than 35 graduate theses and contributed to curriculum design at IIUI, QU, and HBKU. At CIS, he works at Muhammad Bin Hamad Al Thani Center for Muslim Contribution to Civilization (CMCC) and contributes to the Digital Sīrah Initiative.

Associate Professor Fares Al-Ejeh was awarded his Bachelor of Biotechnology degree, and his PhD from the University of Wollongong (NSW, Australia). His first post-doctoral position was industry-funded by Oncaidia Ltd at the Royal Adelaide Hospital/Hanson Institute. .

After five years in industry-oriented research, Dr. Al-Ejeh started his academic career at one of Australia's largest research institutes, the QIMR Berghofer Medical Research Institute. At QIMR, he established his own group, Personalised Medicine, in 2015. His track record includes two granted patents on Apomab and five submitted patent applications undergoing evaluation. He has more than 50 peer-reviewed publications focusing on cancer diagnostics and therapeutics with focus on translational medical research.

Dr. Al-Ejeh has contributed as a keynote speaker at several conferences and as a member of several panels for grant reviews in Australia and internationally. He is an Associate Member of the Australian Academy of Health and Medical Sciences (AAHMS) and an adjunct Associate Professor at the Faculty of Medicine, University of Queensland, Australia in recognition of his teaching and supervision of postgraduate students.

Mahmoud Naas has been in the medical research field and academia for more than 30 years. .

He was previously  an associate professor at Qatar University’sCollege of Health Sciences, where he  developed and delivered a variety of courses. 

As a scientist, Professor Naas’ research activity is an integral part of his academic role; his research has generated several peer reviewed publications, as well as poster presentations at national and international conferences.

Dr. Ramesh Elango is a Postdoctoral Researcher at Qatar Biomedical Research Institute’s Translational Oncology Research Center. He earned his PhD from Bharathidasan University, India, where he researched the anti-atherogenic effects of epigallocatechin gallate from green tea. His work demonstrated that EGCG protects against oxidative damage, reduces inflammation, and regulates key genes involved in cholesterol metabolism. Dr. Ramesh Elango is an expert in advanced techniques such as CRISPR/Cas9-based functional genomics, RNA sequencing, and the profiling of microRNAs and long noncoding RNAs (lncRNAs). 

He later completed postdoctoral studies at King Saud University, Saudi Arabia, where his work led to the discovery of a miRNA-based molecular signature associated with lymph node metastasis in breast cancer. His research focuses on pioneering cancer therapies and identifying novel molecular biomarkers. With over a decade of experience in cancer research, his contributions have been pivotal in identifying therapeutic targets in aggressive cancer subtypes, particularly triple-negative breast cancer (TNBC). He emphasizes the translation of molecular discoveries into clinical applications. Dr. Elango has published over 30 peer-reviewed research articles and book chapters, contributing significantly to the field of oncology.

Dr. Afif Ben Mahmoud is an accomplished geneticist and genome data analyst with extensive expertise in human molecular genetics. He earned an engineering degree in agriculture and animal production, a master's in genetics and biodiversity, and a PhD in molecular and human genetics. With over 12 years of experience in research and academia, Dr. Ben-Mahmoud has dedicated his work to elucidating cellular and molecular mechanisms underlying human genetic diseases, focusing on identifying disease genes and mutations responsible for rare recessive disorders, particularly in Arab populations.

His professional contributions in genetic pathology span from phenotypic and genotypic characterization of patients with monogenic diseases to functional studies aimed at demonstrating the pathogenicity of disease-causing novel genes and gene variations. He has also led numerous projects to decode rare human monogenic diseases, significantly advancing the field. 

Dr. Afif Ben Mahmoud’s notable accomplishments include the first functional analysis of B3GALTL in Tunisian patients with Peters Plus Syndrome, the identification of MAST1 as a novel intellectual disability gene, and confirming the role of B3GALT6 in Al-Gazali Syndrome. Additionally, he has identified 16 autosomal dominant candidate genes in syndromic neurodevelopmental disorders and new candidate loci for intellectual disability and Kallmann syndrome. Dr. Ben-Mahmoud has published 25 high-quality articles in renowned international peer-reviewed journals, with over 500 citations and an h-index of 14.

Dr. Yongsoo Park is an Associate Professor at the College of Health and Life Sciences and a Senior Scientist at Qatar Biomedical Research Institute. He received PhD in investigating exocytosis and plasticity of vesicle fusion at the Pohang University of Science and Technology (POSTECH), South Korea.

After completing his PhD degree in 2009, he worked as a Postdoctoral Researcher at the Max Planck Institute for Biophysical Chemistry, Göttingen, Germany, being trained by a mentor Prof. Reinhard Jahn, a world-renowned scientist by his pioneering research into fusion and neurotransmitter release. In 2015, he was appointed as an Assistant Professor at the Izmir International Biomedicine and Genome Institute where he joined the Department of Molecular Biology and Genetics at the Koç University, Istanbul, Turkey.

In 2019 Dr. Park moved to the Qatar Biomedical Research Institute (QBRI) and is coaffiliated at the College of Health and Life Sciences aiming to model neurological disease with patient-specific hiPSC-derived neurons. His lab focuses on extracellular vesicle biomarkers for autism spectrum disorder (ASD), Parkinson’s disease, and Alzheimer's disease. He also studies lipid dysregulation in neurological disease conditions with a focus on calcium signaling and vesicle fusion. By applying interdisciplinary approaches, his team investigates molecular mechanisms of neurological disorders and the development of therapeutics.